Last checked at 11 May 2022 07:00
Spire Healthcare Group plc
("Spire Healthcare", "the Company" or "the Group")
AGM STATEMENT
11 May 2022
Ahead of its Annual General Meeting later today, Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, provides the following update for the period 1 January 2022 to 30 April 2022.
Notwithstanding the disruption in the first quarter due to the Omicron variant, we are satisfied with our performance in the first four months of 2022. Accordingly, whilst we are yet to enter our busiest trading period, we reiterate our outlook for the full year, as set out in our FY21 results announcement.
We expect to announce our results for the six months ending 30 June on 8 September 2022.
-Ends-
For further information please contact: Spire Healthcare Angus Prentice - Interim Head of Investor Relations
|
+44 (0)20 7427 9000
|
Instinctif Partners Damian Reece Guy Scarborough | +44 (0)20 7457 2020 |
Registered Office and Head Office:
Spire Healthcare Group plc
3 Dorset Rise
London
EC4Y 8EN
Registered number: 09084066
About Spire Healthcare
Spire Healthcare is a leading independent hospital group in the United Kingdom, with 39 private hospitals and eight clinics across England, Wales and Scotland.
Working in partnership with around 8,150 experienced Consultants, Spire Healthcare delivered tailored, personalised care to almost 870,000 in-patients and daycase patients in 2021, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.
The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, Consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 95% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).
Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.